Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   David Turner   and   Victoria Findlay.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.335
         
        
        
     
 
    
        
        - 
            Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts. Transl Oncol. 2022 Jan 25; 17:101350.
            
            
                Score: 0.193
             
- 
            Pubertal mammary development as a "susceptibility window" for breast cancer disparity. Adv Cancer Res. 2020; 146:57-82.
            
            
                Score: 0.169
             
- 
            Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019 Feb; 173(3):559-571.
            
            
                Score: 0.154
             
- 
            AGE metabolites: a biomarker linked to cancer disparity? Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2186-91.
            
            
                Score: 0.114
             
- 
            Understanding the role of ETS-mediated gene regulation in complex biological processes. Adv Cancer Res. 2013; 119:1-61.
            
            
                Score: 0.103
             
- 
            MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer. Breast Cancer Res. 2013; 15(4):R70.
            
            
                Score: 0.103
             
- 
            Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. Prostate. 2011 Dec; 71(16):1723-35.
            
            
                Score: 0.091
             
- 
            Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms. Genes Cancer. 2011 Feb; 2(2):120-9.
            
            
                Score: 0.090
             
- 
            MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. Cancer Res. 2008 Oct 15; 68(20):8499-506.
            
            
                Score: 0.077
             
- 
            Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. Mol Biol Cell. 2008 Sep; 19(9):3745-57.
            
            
                Score: 0.075
             
- 
            Defining ETS transcription regulatory networks and their contribution to breast cancer progression. J Cell Biochem. 2007 Oct 15; 102(3):549-59.
            
            
                Score: 0.072
             
- 
            BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivors. Adv Cancer Res. 2020; 146:83-102.
            
            
                Score: 0.042
             
- 
            Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment. Neoplasia. 2015 May; 17(5):434-48.
            
            
                Score: 0.030
             
- 
            Slug expression enhances tumor formation in a noninvasive rectal cancer model. J Surg Res. 2011 Sep; 170(1):56-63.
            
            
                Score: 0.023